Daniel E. Kolker

Array ( [id] => 4669857 [patent_doc_number] => 20080044917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Rapid induction of Alzheimer\'s amyloid plaque formation by sulfated glycosaminoglycans' [patent_app_type] => utility [patent_app_number] => 11/487149 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11777 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044917.pdf [firstpage_image] =>[orig_patent_app_number] => 11487149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834235 [patent_doc_number] => 20060246065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Fail molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/486345 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 48279 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246065.pdf [firstpage_image] =>[orig_patent_app_number] => 11486345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693982 [patent_doc_number] => 20070015704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Nucleic acid and corresponding protein entitled 238P1B2 useful in treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 11/483302 [patent_app_country] => US [patent_app_date] => 2006-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 172704 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015704.pdf [firstpage_image] =>[orig_patent_app_number] => 11483302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 73711 [patent_doc_number] => 07749716 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Methods of detecting a fragment of neurosecretory protein VGF for diagnosing alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/452477 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13594 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749716.pdf [firstpage_image] =>[orig_patent_app_number] => 11452477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567844 [patent_doc_number] => 20100017894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Mutants of Human App and Their Use for the Production of Transgenice Animals' [patent_app_type] => utility [patent_app_number] => 11/922050 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3911 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20100017894.pdf [firstpage_image] =>[orig_patent_app_number] => 11922050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4459722 [patent_doc_number] => 07879568 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Method for the diagnosis and prognosis of demyelinating diseases' [patent_app_type] => utility [patent_app_number] => 11/915324 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9908 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879568.pdf [firstpage_image] =>[orig_patent_app_number] => 11915324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 220648 [patent_doc_number] => 07608264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Antibodies that bind to pleiotrophin growth factor receptor' [patent_app_type] => utility [patent_app_number] => 11/436244 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12315 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608264.pdf [firstpage_image] =>[orig_patent_app_number] => 11436244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555468 [patent_doc_number] => 08067369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Protection of the retina against laser injury by NAP and related peptides' [patent_app_type] => utility [patent_app_number] => 12/280471 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 12947 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067369.pdf [firstpage_image] =>[orig_patent_app_number] => 12280471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5618972 [patent_doc_number] => 20060188505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Treatment of autism' [patent_app_type] => utility [patent_app_number] => 11/403503 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26102 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188505.pdf [firstpage_image] =>[orig_patent_app_number] => 11403503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677392 [patent_doc_number] => 20060182747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Treatment of autism' [patent_app_type] => utility [patent_app_number] => 11/403502 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26096 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182747.pdf [firstpage_image] =>[orig_patent_app_number] => 11403502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328837 [patent_doc_number] => 08236933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/911300 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 44 [patent_no_of_words] => 45585 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11911300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452605 [patent_doc_number] => 20090068642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Composition and pharmacology of novel alpha6-containing nicotinic acetylcholine receptors' [patent_app_type] => utility [patent_app_number] => 11/387619 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14395 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068642.pdf [firstpage_image] =>[orig_patent_app_number] => 11387619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290429 [patent_doc_number] => 20090023159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Method for the in vitro diagnosis of alzheimer\'s disease using a monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 11/886022 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13494 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023159.pdf [firstpage_image] =>[orig_patent_app_number] => 11886022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732780 [patent_doc_number] => 20060257897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/367172 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34096 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257897.pdf [firstpage_image] =>[orig_patent_app_number] => 11367172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632237 [patent_doc_number] => 20060148707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Use of ligands to GABA beta receptors' [patent_app_type] => utility [patent_app_number] => 11/365437 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1801 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148707.pdf [firstpage_image] =>[orig_patent_app_number] => 11365437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791666 [patent_doc_number] => 20080292639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Humanized Anti-Amyloid Antibody' [patent_app_type] => utility [patent_app_number] => 11/576220 [patent_app_country] => US [patent_app_date] => 2006-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25994 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292639.pdf [firstpage_image] =>[orig_patent_app_number] => 11576220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643446 [patent_doc_number] => 20060281901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Method for the production of amyloid-beta peptide using ubiquitin' [patent_app_type] => utility [patent_app_number] => 11/325390 [patent_app_country] => US [patent_app_date] => 2006-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4974 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281901.pdf [firstpage_image] =>[orig_patent_app_number] => 11325390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675621 [patent_doc_number] => 20080213250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases' [patent_app_type] => utility [patent_app_number] => 11/791289 [patent_app_country] => US [patent_app_date] => 2005-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20852 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213250.pdf [firstpage_image] =>[orig_patent_app_number] => 11791289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5637499 [patent_doc_number] => 20060068472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Compositions to ameliorate protein misfolding and aggregation' [patent_app_type] => utility [patent_app_number] => 11/282495 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29622 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068472.pdf [firstpage_image] =>[orig_patent_app_number] => 11282495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322909 [patent_doc_number] => 20090060899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'COMPOSITION OF ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/718665 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3442 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060899.pdf [firstpage_image] =>[orig_patent_app_number] => 11718665 [rel_patent_id] =>[rel_patent_doc_number] =>)